Osteopontin (OPN) is a secreted, multifunctional, extracellular matrix (ECM), calcium-binding, glycosylated phosphoprotein that is associated with various normal biological functions and pathological processes. OPN is physiologically produced by a wide range of cells and has been identified in various body fluids, playing a crucial role in bone remodeling and vascularization. OPN is also expressed by multiple immune cells, acting as a chemotactic factor, a mediator of cell activation and cytokine production, and an anti-apoptotic factor, thereby regulating inflammation and immune responses. OPN can be involved in the tumorigenesis of various cancer types, including head and neck squamous cell carcinoma (HNSCC), by promoting cell proliferation, adhesion, invasion, and migration through multiple signaling pathways[1][2].
Anti-Mouse osteopontin/SPP1 Antibody (100D3) 是一种抗小鼠 osteopontin/SPP1 的 IgG2c 单克隆抗体,可逆转骨桥蛋白 (OPN) 对 T 细胞的抑制作用并增强细胞毒性 T 淋巴细胞 (CTL) 的杀伤能力,还能提高牙本质密度,可用于研究癌症和牙齿相关疾病(如结肠癌),其同型对照为 Mouse IgG2c kappa, Isotype Control (MS-J64914)。
Anti-Mouse osteopontin/SPP1 Antibody (103D6) 是一种源自小鼠的抗小鼠 osteopontin/SPP1 IgG2c κ 型抗体抑制剂,可增强细胞毒性 T 淋巴细胞的裂解活性并抑制结肠肿瘤生长,还能改善胆总管结扎 (CBDL) 诱导的原发性硬化性胆管炎模型小鼠的肝损伤。
SVVYGLR 是一种骨桥蛋白衍生肽,能够促进成纤维细胞分化为肌成纤维细胞样细胞、促进心肌成纤维细胞产生 III 型胶原蛋白、在体外激活内皮细胞的黏附、迁移及管形成、促进血管形成和伤口愈合以及促进真皮成纤维细胞和角质形成细胞的迁移,可用于血管生成、真皮伤口和骨再生相关研究。
Calcium glucoheptonate 是一种水溶性极强的钙补充剂,能够提高 MG-63 细胞的增殖速率和钙摄入量、增强碱性磷酸酶 (ALP) 的活性、上调成骨相关基因和蛋白质(如胶原蛋白-1 (collagen-1)、骨钙素 (osteocalcin) 和骨桥蛋白 (osteocalcin))的表达,并可用于骨质疏松症和低钙血症的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号